About ARRIUS
Our Vision
At ARRIUS, our vision is to be a global leader in biotechnology, developing solutions that have a positive impact on human health and the environment.
Our Mission
Our Technology
Our Mission
At ARRIUS, our mission is to develop innovative biotechnology solutions that improve people's lives and advance scientific research.
Our Team
Our Technology
Our Mission
Our team consists of experienced scientists and researchers who are passionate about biotechnology and dedicated to achieving our mission.
Our Technology
Our Technology
Our Technology
We use cutting-edge technology and state-of-the-art equipment to develop our biotechnology solutions, ensuring that our products are of the highest quality.
Novel Products
Innovative Monoclonal Antibody (MAb) Development
Innovative Monoclonal Antibody (MAb) Development
Innovative Monoclonal Antibody (MAb) Development
Arrius is committed to advancing the development of novel monoclonal antibodies (MAbs) focused on promising immune-oncology (IO) targets. Our cutting-edge research explores bispecific antibody formats, enabling simultaneous targeting of multiple pathways. In addition, we are developing chimeric antigen receptors (CARs) based on these novel antibodies, unlocking new potential for CAR-T cell therapies in cancer treatment.
Revolutionary Platform Technologies
Innovative Monoclonal Antibody (MAb) Development
Innovative Monoclonal Antibody (MAb) Development
Arrius is at the forefront of biotechnology innovation, advancing platform technologies to transform the industry. We are developing a cutting-edge yeast platform that incorporates human glycans, enhancing the authenticity and functionality of therapeutic proteins. Additionally, our groundbreaking efforts include creating a human naïve antibody phage display library, offering an extensive range of antibodies for discovery and development.
Bispecific Antibody Development
Innovative Monoclonal Antibody (MAb) Development
Bispecific Antibody Development
Arrius is leading the way in bispecific antibody development, transforming the landscape of disease targeting. We are engineering antibodies that can engage multiple disease-related pathways simultaneously, enhancing therapeutic effectiveness. To support efficient production, we’ve developed a high-yield expression platform optimized for bispecific antibodies. Additionally, our in-house purification platform is specifically designed for the efficient purification of heterospecific antibodies, ensuring high-quality and reliable manufacturing processes.
Novel Diagnostic Kits
Innovative Biological Solutions for Sustainable Agriculture
Bispecific Antibody Development
- Human/Bacterial/Fungal DNA Extraction Kit
- Bacterial DNA Extraction Kit
- Fungal DNA Extraction Kit
- Multiplex Pan-Candida Panel Kit
- Multiplex Pan-Fungal Panel Kit
- Multiplex Urogenital Bacterial Panel Kit
- Multiplex Urogenital Bacterial/Fungal Panel Kit
- Candida albicans Kit
- Pan Mucormycosis Kit
- Aspergillus fumigatus Kit
Innovative Biological Solutions for Sustainable Agriculture
Innovative Biological Solutions for Sustainable Agriculture
Innovative Biological Solutions for Sustainable Agriculture
Arrius takes an innovative approach by harnessing the power of beneficial microorganisms to create advanced biological solutions. Utilizing naturally occurring microbes, we offer adaptable pathways for enhancing agricultural practices, including seed treatment, crop production and protection, and soil sustainability. Our microbial solutions not only improve agricultural efficiency but also help reduce the ecological footprint, supporting long-term environmental sustainability.
Innovative Solutions
Drug Discovery
Our cutting-edge drug discovery platform uses advanced molecular modeling and artificial intelligence to identify novel drug targets and accelerate the development of life-saving therapies.
Precision Medicine
Our personalized medicine approach leverages genomic and clinical data to develop individualized treatment plans, improving patient outcomes and quality of life.
Monoclonal Antibody
Arrius is leading the way in biosimilar drug development, leveraging the growing number of monoclonal antibody approvals in recent years. Our experienced team is focused on developing carefully selected biosimilar candidates, particularly monoclonal antibodies used in targeted therapies for cancer, autoimmune disorders, and infectious diseases. By meticulously evaluating factors such as patent expiration, market potential, and clinical profiles, we have identified our next wave of candidates. Our strategy prioritizes precise selection and fosters opportunities for collaborations or client-based partnerships. Join Arrius in advancing accessible solutions in the dynamic field of monoclonal antibody therapies, and help us contribute to the crucial goal of delivering affordable, high-quality healthcare.
Recombinant Peptides
Arrius is committed to expanding access to essential diabetes care. Our portfolio features a range of biosimilar peptide products aimed at treating both type 1 and type 2 diabetes. With a strong emphasis on affordability and quality, we collaborate with partners to bring these crucial therapies to market or provide technology transfer options to clients. Join us in our mission to support the diabetes community with dependable solutions, and together, we can make a meaningful impact on the lives of those who need it most.
Innovative Cell and Gene Therapies
- Stem Cell Therapy Advancement
- Cell Secretomes Exploration
- Cell Exosome Harvesting
- Large Scale Plasmid Manufacturing
- Viral Vector Innovation
- Viral Vector Packaging Excellence
- Genetic Construct Characterization
Revolutionising Science
Gene Therapy
Immunotherapy
Immunotherapy
Our gene therapy approach aims to correct genetic defects by delivering therapeutic genes to the affected cells, potentially curing a wide range of genetic diseases.
Immunotherapy
Immunotherapy
Immunotherapy
Our immunotherapy platform harnesses the power of the immune system to fight cancer and other diseases, using engineered immune cells and other novel approaches.
Cell Therapy
Immunotherapy
Regenerative Medicine
Our cell therapy expertise allows us to engineer cells to target and treat a range of diseases, including cancer, autoimmune disorders, and more.
Regenerative Medicine
Artificial Intelligence
Regenerative Medicine
Our regenerative medicine solutions use stem cells and other advanced techniques to repair and replace damaged tissues, potentially providing a cure for previously untreatable conditions.
Artificial Intelligence
Artificial Intelligence
Artificial Intelligence
Our AI-powered drug discovery and development platform uses machine learning and other advanced techniques to accelerate the discovery of new treatments.
